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Abnormalities in sleep and circadian rhythms are central features
of bipolar disorder (BP), often persisting between episodes. We report
here, to our knowledge, the first systematic analysis of circadian
rhythm activity in pedigrees segregating severe BP (BP-I). By analyzing
actigraphy data obtained from members of 26 Costa Rican and
Colombian pedigrees [136 euthymic (i.e., interepisode) BP-I individuals
and 422 non–BP-I relatives], we delineated 73 phenotypes, of which
49 demonstrated significant heritability and 13 showed significant
trait-like association with BP-I. All BP-I–associated traits related to ac-
tivity level, with BP-I individuals consistently demonstrating lower
activity levels than their non–BP-I relatives. We analyzed all 49 heri-
table phenotypes using genetic linkage analysis, with special empha-
sis on phenotypes judged to have the strongest impact on the biology
underlying BP. We identified a locus for interdaily stability of activity,
at a threshold exceeding genome-wide significance, on chromosome
12pter, a region that also showed pleiotropic linkage to two addi-
tional activity phenotypes.
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Quantitative sleep and activity measures are hypothesized tobe endophenotypes for bipolar disorder (BP). Disturbance
of sleep and circadian activity typically precedes and may pre-
cipitate the initial onset of BP (1, 2). Decreased sleep and in-
creased activity occur before and during manic and hypomanic
episodes. Conversely, increased sleep and decreased activity
characterize BP–depression. Extreme diurnal variation in mood
features prominently in both mania and depression, whereas shifts
in circadian phase (the time within the daily activity cycle at which
periodic phenomena such as bed time or awakening occur) can
induce mania and ameliorate symptoms of BP–depression (3).
Twin studies have identified multiple heritable sleep and ac-
tivity phenotypes, including sleep duration, sleep quality, phase
of activity preference and sleep pattern, and sleep architecture
variables [e.g., the amount of slow wave and rapid eye movement
(REM) sleep (4) and polysomnography profiles during non-
REM sleep (5)]. Euthymic BP individuals, compared with healthy
controls, display trait-like alterations in several such phenotypes—
for example, sleep time and time in bed, sleep onset latency, and
periods of being awake after sleep onset (6). However, no prior
investigations have assayed the heritability of such phenotypes in
BP individuals and their relatives.
We report here the delineation of sleep and activity BP endo-
phenotypes through investigations of 26 pedigrees (n = 558)
ascertained for severe BP (BP-I), from the genetically related
populations of the Central Valley of Costa Rica (CR) and Anti-
oquia, Colombia (CO) (7–9). Pedigrees ascertained for multiple
cases of severe BP (BP-I) should be enriched for extreme
values of quantitative traits that are BP endophenotypes, en-
hancing their utility for genetic mapping studies of such pheno-
types. Additionally, such pedigrees derived from recently expanded
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founder populations are likely to show increased frequencies for
many deleterious alleles—another feature that will enhance their
utility for mapping these traits (10, 11). We previously described, in
these pedigrees, multiple heritable and BP-associated pheno-
types from the domains of temperament, neurocognition, and
neuroanatomy (10).
Actigraphy (activity measurement using wrist-worn acceler-
ometers) can be conducted over prolonged periods without im-
pinging on an individual’s usual activities, enabling assessment of
sleep and activity on a scale sufficient for genetic investigations.
Actigraphy data on sleep quality and duration correlate strongly
with those obtained through polysomnography, the gold standard
for sleep research (12). Using actigraphy, one can estimate the
main circadian activity parameters, which follow a sinusoidal
waveform with a ∼24-h period: phase, amplitude (the strength of
circadian rhythms, as measured by the difference in the amount
of activity between active and inactive moments), and coherence
of the rhythm (the degree of consolidation and stability of ac-
tivity, rest, and sleep). Finally, actigraphy enables quantification
of BP-associated features, such as fragmentation of rest and
activity within and between days, that do not fit a sinusoidal
waveform and cannot be analyzed parametrically (13).
We recorded activity in euthymic BP-I individuals and their
non–BP-I relatives from the CR and CO pedigrees for, on av-
erage, 14 consecutive days. For each actigraphy phenotype, we
evaluated association with BP-I, assessed the heritability of each
trait, and performed genome-wide genetic linkage analyses on all
significantly heritable traits.
Results
Through actigraphy, we obtained activity recordings (illustrated
in Fig. S1) from 638 members of 26 CR and CO pedigrees. After
applying quality control (QC) procedures (SI Methods) that led
to the exclusion of 80 recordings (Fig. S2), we analyzed activity
data from 558 individuals, including 136 BP-I individuals and 422
of their non–BP-I relatives (Table 1). A series of algorithms
obtained from published sources (14–17) were then applied to
the activity data to obtain 116 quantitative sleep and activity
phenotypes. These phenotypes can be classified into six broad
domains that quantified patterns of activity and sleep during the
major rest period of the day (i) and during the awake period (ii),
the fragmentation or consolidation of activity (iii), overall ac-
tivity levels (iv), and the fit of daily activity patterns to curves
based on sine and cosine functions (using two different ap-
proaches) (v and vi). Details on the construction of phenotypes
that fall into each domain are provided in SI Methods.
To reduce the multiple testing burden and eliminate completely
redundant variables, we calculated pair-wise correlations among
all 116 phenotypes (Fig. S3) and performed a hierarchical clus-
tering analysis using 1 – correlation as the distance metric. We
then selected one representative phenotype from each cluster,
yielding 73 phenotypes (Fig. S3), which we analyzed further as
described below. The 43 phenotypes excluded at this stage were
very highly correlated with other phenotypes, all with r > 0.90 and
most with r > 0.99.
Heritability of Phenotypes and Their Association to BP-I. Estimating the
familial aggregation of the 73 phenotypes (an indicator of herita-
bility) and their relationship to BP-I allowed us to determine which
phenotypes have a significant genetic component, to proceed with
analyses to identify genes contributing to phenotypes that are po-
tentially important in the etiology of BP-I. We subjected each
phenotype to an inverse-normal transformation, and to control for
covariates, we regressed [in the software SOLAR (Sequential
Oligogenic Linkage Analysis Routines) (18)] the transformed
phenotypes on age, gender, and country. The residuals from this
Table 1. Sample characteristics and recording days by country and family
Family n (BP-I cases) Female Mean age (SD), range Mean recorded days (SD), range
CO All 269 (66) 58% 46.3 (16.6), 18–83 15.1 (2.1), 7–24
CR All 290 (70) 53% 49.2 (16.0), 17–88 15.8 (2.9), 6–27
CO4 33 (7) 61% 42.0 (17.2), 18–76 15.1 (2.3), 13–24
CO7 96 (23) 53% 44.8 (17.0), 18–80 14.8 (1.6), 7–21
CO8 5 (2) 60% 40.8 (12.8), 24–54 14 (4.9), 7–21
CO10 22 (5) 73% 53.4 (15.4), 32–77 15.4 (2), 14–21
CO13 14 (4) 57% 42.1 (14.7), 18–66 17.1 (3.1), 14–21
CO14 13 (4) 46% 43.8 (15.4), 20–74 14.1 (2.4), 10–21
CO15 19 (4) 58% 41.7 (15.3), 19–73 14.5 (1.6), 12–20
CO18 20 (6) 55% 59.3 (14.2), 34–77 15.2 (1.9), 14–20
CO23 21 (6) 67% 45.0 (15.2), 18–83 15.3 (1.9), 14–20
CO25 8 (2) 63% 56.5 (13.5), 45–82 15.6 (2.6), 14–21
CO27 18 (3) 67% 46.7 (16.8), 18–74 15.4 (1.8), 14–21
CR001 5 (1) 60% 56.0 (11.3), 44–68 19.6 (2.6), 15–21
CR004 37 (7) 51% 55.6 (13.5), 30–84 15 (1.9), 12–21
CR006 7 (2) 29% 52.7 (11.8), 38–66 13.9 (4.1), 6–20
CR007 4 (2) 50% 47.0 (6.6), 39–55 13.8 (0.5), 13–14
CR008 9 (3) 44% 43.7 (16.1), 21–68 15.7 (2.5), 14–20
CR009 25 (6) 60% 40.6 (14.4), 20–74 15.6 (2.8), 12–22
CR010 12 (3) 58% 43.9 (15.9), 21–74 14.2 (2.2), 11–19
CR011 9 (2) 56% 48.8 (23.2), 21–86 18.2 (3), 14–21
CR012 19 (5) 68% 40.8 (15.3), 20–68 17 (3.2), 14–21
CR013 5 (2) 80% 52.2 (19.3), 35–74 15.4 (2.2), 14–19
CR014 2 (1) 50% 45.0 (2.8), 43–47 14.5 (0.7), 14–15
CR015 8 (1) 63% 51.6 (14.2), 38–71 18.4 (2.2), 16–21
CR016 13 (4) 38% 50.1 (14.5), 19–66 16.8 (2.6), 13–21
CR201 125 (28) 51% 50.6 (16.2), 17–88 15.8 (3.1), 7–27
CR277 9 (3) 56% 49.3 (11.6), 37–71 14.1 (0.3), 14–15
Grand total 558 (136) 56% 47.8 (16.3), 17–88 15.4 (2.6), 6–27
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regression were assessed for heritability and for a mean difference
between BP-I individuals and their non–BP-I relatives.
Of the 73 phenotypes, 49 (67%) demonstrated significant
heritability. Heritable phenotypes included measures related to
sleep and activity duration, timing, fragmentation, and consoli-
dation; activity levels and variability; and the timing and peri-
odicity of mean daily activity (Fig. 1).
Thirteen phenotypes (18%) were significantly associated with
BP-I, of which 12 (92%) were also heritable (Fig. 1 and Fig. S4).
BP-I subjects awoke later and slept longer than non–BP-I sub-
jects (phenotypes, mean of sleep offset time and mean sleep
duration). Outside of the rest period, BP-I individuals were, on
average, awake fewer minutes than non–BP-I individuals (phe-
notypes, mean of awake duration and mean of total minutes
scores as awake) and had more variability in the time during the
awake period scored as sleeping (phenotype, SD of the total
minutes scored as sleep). Similar to previous studies (16, 19), we
found that euthymic BP-I individuals display lower activity levels
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Fig. 1. Polar histogram of heritability traits and association to BP-I. The inner histogram represents the heritability estimate (h2) in yellow–green. The middle
histogram represents the association to BP-I; positive associations with BP-I are presented in red (i.e., the trait has a higher value in those with BP-I), whereas
negative associations are presented in blue (indicating those with BP-I have lower values on the trait). The outer histogram summarizes the heritable traits
(black) and the phenotypes associated with BP-I (green). hrs, hours; mins, minutes; no., number.
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than non–BP-I individuals, by multiple measures: amplitude; L5,
5-h period of minimal activity; median activity; mean activity in
6-h windows; and two parameters related to the amplitude and
phase of curve fits to mean daily activity (parameter B from the
fit of the Hill transformation to the daily activity profile and
Cosinor parameter Beta).
Linkage Analysis of Selected Heritable Traits. To identify genetic loci
with the largest impact on sleep and activity phenotypes in the
BP-I pedigrees, we conducted genome-wide linkage analysis using
a dense set of SNPs. Our primary analyses focused on 13 pheno-
types that we considered most relevant to BP. These phenotypes
included traits with prior evidence of BP association, traits that
showed strong BP-I association in our pedigrees, and traits bi-
ologically relevant to fragmentation or consolidation of circa-
dian activity or with biological relevance to phase (Table 2).
Using SOLAR, we performed multipoint linkage analysis on
these 13 phenotypes. The strongest linkage was for the rest–
activity phenotype Interdaily Stability (IS), that represents the
degree of variability of activity level on an hourly basis from day-
to-day (Fig. 2), for which we observed a maximum LOD [loga-
rithm (base 10) of odds] score (4.73, 4 Mb from chromosome
12pter), exceeding the traditional genome-wide significance
threshold (P < 10−4). Interdaily stability linkage remains genome-
wide significant at the 0.05 alpha level, after correcting for the
13 phenotypes (empirical P values associated to the highest
LOD score and to the smallest Simes’ P value are 0.03 and 0.02,
respectively). The linkage evidence for interdaily stability di-
minishes only slightly when including BP-I status as a covariate
(LOD = 4.65; Table S1).
Fig. 3 presents a summary of the significance of linkage results
considering all 49 heritable phenotypes (20). Two linkage peaks
stand out. The largest peak includes the interdaily stability
linkage on chromosome 12pter, having a Simes P value < 0.0001.
In the same region of linkage to interdaily stability, we observed
suggestive linkage for two additional phenotypes (Fig. 4): the
mean number of sleep bouts in the awake period, and amplitude
(the difference in activity between the 5 most active hours and
the 10 least active hours), with peak LOD scores, respectively, of
2.53 (8 Mb from pter) and 2.13 (1 Mb from pter). Interdaily sta-
bility and mean number of sleep bouts show moderately negative
phenotypic correlation (rhop = –0.51) but strongly negative ge-
netic correlation (rhog = –0.93); joint multipoint linkage analysis
suggests complete pleiotropy, indicating a common genetic
component to both phenotypes, centered 4 Mb from 12pter
(LOD = 3.35); lower interdaily stability indicates a weaker
rhythm, while a lower value of mean number of sleep bouts is
associated to a more consolidated rhythm, leading to a negative
correlation between these variables. Amplitude and interdaily
stability display phenotypic and genotypic correlation of a
similar magnitude, albeit in a positive direction (rhop = 0.51
and rhog = 0.92); their joint linkage analysis (LOD = 3.41)
suggests near-complete pleiotropy between these phenotypes, at
the same location.
A second (nonsignificant) linkage peak on chromosome 1q
displayed LOD > 3.0 for four correlated phenotypes related to
the SD of sleep onset and activity (SD of the time of sleep onset,
LOD 3.9 at 183 Mb; SD of the active phase, LOD 3.6 at 185 Mb;
SD of the time of midsleep, LOD 4.3 at 186 Mb; SD of the total
minutes awake, LOD 3.4 at 186 Mb). These phenotypes all have a
pair-wise genetic correlation >0.85, as is reflected in joint linkage
results suggesting complete pleiotropy among them (joint LOD
scores range from 3.1 to 4.2 at 185 Mb; Table S2).
Discussion
We report here, to our knowledge, the first large-scale delineation
of sleep and activity phenotypes in BP-affected individuals and
their relatives. More generally, it is the first genetic investigation
of such a comprehensive set of sleep and circadian measures in
any human study.
Phenotypes significantly associated to BP-I paint a consistent
picture; activity is lower in euthymic BP-I individuals than in their
non–BP-I relatives, reflecting a longer sleep duration, with a later
time of sleep offset and rest offset, resulting in a shorter duration
of the active phase. Furthermore, during the active phase, BP-I
individuals have fewer total minutes scored as awake and more
variability in the total minutes scored as asleep. Such individuals
also display lower amplitude, mainly due to their lower activity
level during the least active hours of the day.
As the BP-I individuals who participated in the study were all
euthymic at the time of recording, the phenotypes that we ob-
served could be considered representative of the remission phase
of the disorder. Previous studies have suggested that distur-
bances in sleep and circadian activity are early signs of manic
episodes, particularly in individuals affected with rapid-cycling
forms of BP (1, 2). We did not observe a high rate of subsequent
mania among those BP-I individuals in whom we detected the
most extreme sleep and activity phenotypes; however, it is pos-
sible that we may have missed such a relationship given that we
Table 2. Thirteen phenotypes chosen for the primary linkage analysis
Phenotype Trait Importance
Amplitude Relative amplitude BP-I associated (19)
Amplitude Association with BP-I in the present study
Median of activity level Association with BP-I in the present study
Phase Time of sleep onset BP-I associated (17)
Time of sleep offset BP-I associated (17)
Hill acrophase Biologically relevant for phase
Fragmentation/ consolidation IV, Intradaily Variability in activity BP-I associated (17)
IS, Interdaily Stability in activity BP-I associated (17)
Mean of the number of sleep bouts
during the awake period
Biologically relevant to
fragmentation/consolidation
Mean of the length of sleep bouts
during the sleep period
Biologically relevant to
fragmentation/consolidation
Efficiency of sleep WASO, total minutes in awake bouts
after sleep onset
BP-I associated (24)
Mean of awake duration Association with BP-I in the present study
Mean total minutes scored as awake
during the awake period
Association with BP-I in the present study
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did not systematically monitor clinical state after the 2-wk re-
cording period.
Our observation of longer sleep duration in BP-I individuals
accords with the results of a meta-analysis conducted in euthymic
BP cases compared with controls (6). However, although the meta-
analysis observed a difference between cases and controls in sleep
onset latency, we did not observe such a difference between BP-I
individuals and their non–BP-I relatives. Our study differs from the
previous investigation in two ways: First, whereas it compared BP
cases (defined broadly) to normal controls, we compared BP cases
(defined narrowly) with participants defined only by the absence of
BP-I. Second, our comparisons involved close relatives rather than
independent participants.
We evaluated the possible effects of medication use on the
association of activity phenotypes to BP-I. Twelve variables, in-
cluding several measuring mean activity levels, were lower for
BP-I subjects on neuroleptics than for those not prescribed these
agents. When subjects receiving neuroleptics were removed from
the analysis, however, activity levels remained significantly lower
in BP-I subjects for the majority of variables (Table S1). Anti-
depressant medication and lithium treatment appeared to have
no significant effect on the group differences except for one
variable, mean activity from midnight to 6:00 AM, which was
lower in subjects taking lithium. The finding of decreased activity
in BP-I subjects also remained significant, when lithium-treated
patients were removed from the analysis.
The size and composition of the pedigree set enabled us to
identify significant heritability for most measures that we evalu-
ated. This finding encouraged us to conduct, to our knowledge,
the first genome-wide mapping study of quantitative traits repre-
senting the most important features of human circadian behavior:
phase, amplitude, and rhythm coherence or robustness.
Previous studies of rare, autosomal dominant circadian rhythm
disorders have implicated genes [including PER2 (PERIOD2),
Fig. 2. Representation of the multipoint LOD scores on different chromosomes (which are depicted in alternating violet and black) for 13 traits that we
considered of highest biological significance. Blue line indicates an LOD score of 3.3, corresponding to a P value of 5 × 10−5. Mins, minutes; no., number.
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CK1δ (Casein kinase 1 delta), and DEC2 (BHLHE41, basic
helix-loop-helix family member e41)] already known to function in
the regulation of the circadian clock (21–23). In contrast, the
linkage regions identified here for quantitative activity traits do
not include any known clock genes. Similarly, prior work has
found little evidence that such genes play a role in quantitative
circadian activity phenotypes in mice (24).
Our most striking genetic finding was the genome-wide sig-
nificant linkage for interdaily stability, a measure of day-to-day
variability of the waveform of activity, near chromosome 12pter.
The suggestive linkage peaks in this region for two additional
phenotypes, amplitude and mean number of sleep bouts, which
show pleiotropy with interdaily stability in bivariate linkage analy-
sis, underline its importance for the regulation of circadian activity.
Several genes in this region could plausibly influence activity-
related behaviors, including the histone lysine demethylase
JARID1a (KMD5A) and calcium channel subunit 1C (CACNA1C).
JARID1a forms a complex with the core clock proteins CLOCK
and BMAL1, thereby recruiting them to the Per2 promoter. On this
promoter, JARID1a enhances Per2 transcription through a de-
methylase-independent mechanism. Depletion of JARID1a, in
mammalian cells in culture, shortens the circadian period (25).
CACNA1C demonstrates a circadian expression pattern. Its
loss affects the ability to phase advance wheel running behavior
in mouse after a light pulse and impairs the induction of Per2 and
Per1 expression (26). In multiple GWASs (genome-wide associ-
ation studies), CACNA1C has shown genome-wide significant
associations to BP (27–29) as well as to other psychiatric dis-
orders (27). Studies in two cohorts have suggested a role of
variants in CACNA1C in sleep habits and insomnia (30, 31),
and CACNA1C knockout mice display lower EEG spectral
power and impaired REM sleep recovery (32). These diverse
GWAS findings, together with the pleiotropic effects that we
observed, and the moderate association in our dataset between
interdaily stability and BP-I, suggest that variants in this region
could have a complex phenotypic impact beyond BP; however,
SNPs in CACNA1C known to be associated to BP (30, 31) are
not associated to interdaily stability and when included as
covariates in our linkage analysis do not decrease our evidence
for linkage to chromosome 12. Whole-genome sequencing un-
derway in these pedigrees will enable us to evaluate, in relation
to 12pter-linked sleep and activity phenotypes, variants in the
genes noted above as well as other genes in this region.
Although the study demonstrates the feasibility of large-scale
genetic investigation of human circadian activity, its limitations
reflect the imprecision of actigraphy as a representation of cir-
cadian rhythm. By conducting the recordings while individuals
were carrying out their usual activities, we were unable to exclude
the possibility that various masking and confounding factors, such
as social and natural/artificial light entrainment, could have
influenced our results. An alternative study design might have
been to analyze sleep and circadian parameters in traditional
laboratory conditions, such as constant routine or forced desyn-
chrony (33). We did not, however, consider such a design feasible.
Not only were we concerned that exposure of BP-I–affected in-
dividuals to such conditions might trigger an acute episode, but
such laboratory studies are extremely expensive and labor-
intensive, making the recording and analysis of circadian activity and
sleep patterns in such a big cohort virtually impossible.
To counter the limitations noted above, future investigations
of circadian rhythms in these pedigrees will use molecular assays
that record circadian rhythms in skin fibroblasts, from affected
and unaffected individuals, in real time for several days. From
this analysis, we will obtain information on the period length of
the cells as well as parameters such as amplitude, phase, and
entrainment. Compared with behavioral phenotypes, circadian
phenotypes resulting from this analysis will more directly reflect
the underlying genetic properties of the clock (34, 35).
In summary, this is the first large-scale analysis of activity
phenotypes in pedigrees ascertained for BP. We demonstrate
lower activity in euthymic BP-I individuals compared with their
non–BP-I relatives and heritability for phenotypes assaying mul-
tiple facets of sleep and activity. The genome-wide significant
linkage to interdaily stability, a phenotype associated with BP in
case-control studies (17), provides an opportunity to identify se-
quence variants contributing to the biological underpinnings of
this disorder.
Methods
Activity Recording Procedures. We used the Actiwatch Spectrum (Philips
Respironics) to record activity count (in 1-min epochs) and ambient light level.
At the time of purchase and after annual servicing and battery replacement,
we performed two independent procedures, to calibrate devices and mini-
mize interdevice variability (SI Methods). Project staff in CR and CO provided
calibrated Actiwatches to all participants, whom we ascertained as reported
previously (10) and who provided informed consent, as approved by US and
local Institutional Review Boards (University of California–Los Angeles
Medical Institutional Review Board, the Ethics Committees of the University
of Costa Rica, the Ethics Committees of the University of Antioquia, and
University of Texas Southwestern Medical Center Institutional Review
Board). As close as possible to the time of other phenotypic assessments, we
placed the Actiwatch on the nondominant wrist and instructed participants
to not remove it for 14 d, press the marker button when they lay down to
Fig. 3. Multipoint linkage analysis across all 49 heritable phenotypes.
Chromosomes are represented in alternating colors (light gray–dark gray).
Fig. 4. Multipoint linkage analysis of the most biological significant phe-
notypes; depiction of the region of pleiotropic linkage on chromosome 12p.
no., number.
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sleep and when they got out of bed, and keep a sleep log, registering bed
times and nap times.
Activity Data Analysis. Two research assistants visually inspected activity re-
cordings (Fig. S1) for gross abnormalities or deficiencies in data collection
that would exclude them from analyses (SI Methods). For acceptable re-
cordings, we first delineated the rest period for each 24 h (the interval from
the time an individual gets into bed until he/she gets out of bed), combining
actigraphy data with information from sleep logs using an algorithm written
in R (36) (SI Methods and Figs. S5 and S6). We analyzed sleep parameters
using a script written in R, based on published Respironics definitions and
algorithms (14–17). R scripts are available upon request.
Analysis of Heritability and Association to BP-I. As in the previous endophe-
notyope analyses of these pedigrees (10), we analyzed heritability and asso-
ciation to BP-I in SOLAR (18), which implements a variance component method
to estimate the proportion of phenotypic variance due to additive genetic
factors (narrow sense heritability). Under the null hypothesis that the value of
the additive genetic variance is zero, testing significance of the estimate of
genetic variance compared with the null value is a one-sided test.
Variance components analysis is sensitive to outliers and nonnormal trait
distributions. To guard against statistical artifacts induced by skewed distri-
butions, before analyses we used, in SOLAR, a standard rank-based procedure
(37) to inverse-normal transform all phenotypes and thereby avoid correla-
tions between relatives or inflated heritability estimates (38).
We regressed all phenotypes on three covariates [sex, age, and country
(CR vs. CO), also used in all analyses described below]; of six potential
covariates that we evaluated, only these three significantly affected phe-
notype values (SI Methods). We initially considered household effects as a
potential source of phenotypic variation; however, we found that “house-
hold” was not a significant component of variation for any phenotype and
therefore did not include it as a variable in further models. We implemented
regressions in SOLAR, using pedigree structures, using residuals from these
models in all further analyses. We tested for BP-I association (difference in
trait means between individuals with and without this diagnosis), using
SOLAR to account for dependencies among relatives in a two-sided test of
the null hypothesis of no association. As the non–BP-I category includes in-
dividuals diagnosed with other psychiatric disorders, this is not a case-control
comparison (and likely underestimates the degree of BP-I association of each
measure). We controlled family-wise error rate at the 0.05 level, using a
Bonferroni-corrected threshold for each test (heritability and BP-I associa-
tion; P < 6.7 × 10−4).
Genome-Wide Genotyping and Quantitative Trait Linkage Analysis. Genotyping
of 856 individuals, performed in three batches, used the Illumina Omni 2.5
chip (for QC details, see SI Methods). We implemented genome-wide mul-
tipoint linkage analysis in SOLAR, which uses a variance component
approach to partition the genetic covariance between relatives for each trait
into locus-specific heritability (h2q) and residual genetic heritability (h2r).
The software package Loki (39, 40), which implements Markov Chain Monte
Carlo, provided estimated multipoint identical by decent (MIBD) allele-
sharing among family members from genotype data, using a linkage dis-
equilibrium (LD)-pruned subset of markers that passed QC procedures (SI
Methods). We performed linkage analysis at 1-cM intervals focusing pri-
marily on phenotypes that we considered most relevant to BP; for these
phenotypes, we also performed a secondary genome-wide linkage analysis
including BP status as a covariate. There were 558 individuals with genotype
and phenotype data for all analyses (136 BP-I and 422 non–BP-I). Power
analysis in SOLAR, using simulated data, indicated that this sample size pro-
vided >80% power to detect a LOD score of 3, provided the estimate of locus-
specific heritability was ≥35%.
To evaluate the significance of the strongest linkage finding while ap-
propriately accounting for multiple comparisons among phenotypes most
relevant to BP, we used simulations. Specifically, we used gene dropping to
generate genotypes consistent with the relationships between the pedigree
members, independent from the recorded phenotypic values. This approach
allowed us to simulate null datasets that maintain the specific dependency
structure existing across these 13 phenotypes. We used gene-drop simulations
to construct a null distribution of LOD scores, rather than permutingphenotypic
values, because individuals in pedigrees are not exchangeable; phenotypic
permutation would likely render most of our phenotypes nonheritable,
therefore biasing the null distribution toward zero LOD scores. For each of 100
datasets so generated, we carried out linkage analysis for each phenotype,
recording both the highest LOD score obtained and themost significant P value
for the hypothesis of no linkage to any phenotype (Simes P value).
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